You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High density lipoprotein (HDL) cholesterol

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Low-density Lipoprotein Cholesterol Reduction With

Recruiting
  • Acute Coronary Syndrome
  • Dyslipidemias
  • Banja Luka, Republic Of Srpska, Bosnia and Herzegovina
    University Clinical Centre of the Republic of Srpska
Oct 17, 2021

Peritoneal Dialysis Trial (Melatonin, )

Not yet recruiting
  • Peritoneal Dialysis
  • Melatonin
  • placebo
  • (no location specified)
Oct 21, 2023

Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Risk Equivelents, Elevated Low Density

Active, not recruiting
  • Atherosclerotic Cardiovascular Disease
  • +2 more
  • Sale, Cheshire, United Kingdom
  • +16 more
Jan 20, 2023

Cholesterol, LDL, Cholesterol, HDL, Research Subjects Trial in College Station (Low-fat ground beef, High-fat ground beef)

Completed
  • Cholesterol, LDL
  • +2 more
  • Low-fat ground beef
  • High-fat ground beef
  • College Station, Texas
    Texas A&M University
Apr 9, 2021

Hypercholesterolemia Trial in Worldwide (inclisiran sodium, Placebo)

Active, not recruiting
  • Hypercholesterolemia
  • inclisiran sodium
  • Placebo
  • Lanzhou, Gansu, China
  • +44 more
Feb 7, 2022

Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • NGGT006
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Nov 5, 2023

Familial Hypercholesterolemia Trial (phytosterol, krill oil, Placebo phytosterol)

Not yet recruiting
  • Familial Hypercholesterolemia
  • phytosterol
  • +3 more
  • (no location specified)
Jan 13, 2023

Homozygous Familial Hypercholesterolemia Trial in Worldwide (Evinacumab)

Active, not recruiting
  • Homozygous Familial Hypercholesterolemia
  • Wilmington, Delaware
  • +10 more
Jan 30, 2023

Hypercholesterolemia Trial (HSK31679 low dose, HSK31679 medium dose, HSK31679 high dose)

Not yet recruiting
  • Hypercholesterolemia
  • HSK31679 low dose
  • +4 more
  • (no location specified)
Mar 20, 2023

Dietary Antioxidants and Thiol Disulfide Homeostasis in T2DM

Completed
  • Diabetes Mellitus, Type 2
  • Antioxidative Stress
  • Dietary antioxidant intake
  • Ankara, Turkey
    Ankara Yıldırım Beyazıt University
Jan 16, 2023

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

Hyperlipidemia Trial in Changsha, Chengdu, Beijing (100 mg inclisiran sodium (equivalent to 94.5 mg inclisiran), Placebo, 300 mg

Completed
  • Hyperlipidemia
  • 100 mg inclisiran sodium (equivalent to 94.5 mg inclisiran)
  • +2 more
  • Changsha, Hunan, China
  • +2 more
Dec 2, 2021

Hypercholesterolemia Trial in Worldwide (ALIROCUMAB SAR236553 (REGN727), (for injection training only), ezetimibe)

Completed
Has Results
  • Hypercholesterolemia
  • ALIROCUMAB SAR236553 (REGN727)
  • +5 more
  • Graz, Austria
  • +152 more
Mar 21, 2022

Elevated Triglycerides, Hypertriglyceridemia Trial in Chicago, Indianapolis (Average American Diet With SoFAS Replaced With

Recruiting
  • Elevated Triglycerides
  • Hypertriglyceridemia
  • Average American Diet With SoFAS Replaced With Avocado
  • Average American Diet
  • Chicago, Illinois
  • +1 more
Mar 8, 2022

Hyperlipidemia Trial in Worldwide (biological, drug, other)

Completed
Has Results
  • Hyperlipidemia
  • Evolocumab
  • +3 more
  • Birmingham, Alabama
  • +82 more
Nov 4, 2022

Improving Systolic BP and LDL-C Compared to Conventional

Not yet recruiting
  • Hyperlipidemias
  • Hypertension
  • Rosuvastatin, Olmesartan Medoxomil
  • (no location specified)
Jun 6, 2022

Familial Hypercholesterolaemia Trial in Czechia (Total cholesterol (TC) level test and direct Low density lipoprotein

Recruiting
  • Familial Hypercholesterolaemia
  • Total cholesterol (TC) level test and direct Low density lipoprotein cholesterol (LDL-C) level test
  • DNA testing
  • Brno, Czechia
  • +10 more
Nov 25, 2022

Familial Hypercholesterolemia - Heterozygous Trial in Worldwide (Inclisiran, Placebo)

Recruiting
  • Familial Hypercholesterolemia - Heterozygous
  • Tucson, Arizona
  • +76 more
Aug 8, 2022

Dyslipidemias, Stroke, Acute Ischemic Trial in Ansan, Seoul (combination of high-dose rosuvastatin and ezetimibe, high-dose

Recruiting
  • Dyslipidemias
  • Stroke, Acute Ischemic
  • combination of high-dose rosuvastatin and ezetimibe
  • high-dose rosuvastatin single administration
  • Ansan, Gyeonggi-do, Korea, Republic of
  • +2 more
May 22, 2023

The Effect of Levetiracetam on Lipid Profile in Children

Completed
  • Epilepsy
  • +3 more
  • the blood sample test results
  • Altınoluk, Balikesi̇r, Turkey
    Ataturk City Hospital
Mar 2, 2022

Paraoxonase and HDL Qualities in Glycaemia and Inflammation

Recruiting
  • Diabetes Mellitus
  • Bariatric Surgery Candidate
    • Manchester, Lancashire, United Kingdom
      Central Manchester University Hospitals NHS Foundatioon Trust
    Apr 7, 2022

    Coronary Disease Trial (MK0653, ezetimibe / Duration of Treatment: 27 Weeks, MK0733, simvastatin / Duration of Treatment: 27

    Completed
    • Coronary Disease
    • MK0653, ezetimibe / Duration of Treatment: 27 Weeks
    • +2 more
    • (no location specified)
    Feb 7, 2022

    Osteoarthritis Trial in Santa Monica (Fortetropin supplement, Cheese protein)

    Active, not recruiting
    • Osteoarthritis
    • Fortetropin supplement
    • Cheese protein
    • Santa Monica, California
      Citruslabs
    Aug 27, 2023

    The Very Large Database of Lipids (VLDL)

    Active, not recruiting
    • Lipid Disorders and Lipid Measurement
      • Baltimore, Maryland
        Johns Hopkins University
      Aug 1, 2022